E2 ModerateModerate confidencePEM not requiredObservationalPeer-reviewedReviewed
The economic cost of chronic fatigue and chronic fatigue syndrome in UK primary care.
McCrone, P, Darbishire, L, Ridsdale, L et al. · Psychological medicine · 2003 · DOI
Quick Summary
This study looked at how much money ME/CFS costs patients and society in the UK. Researchers tracked what healthcare services patients used over 3 months and how much work they missed. They found that ME/CFS is very expensive, costing an average of £3,515 per patient over 3 months, mostly because patients need help from family and friends and can't work, rather than from doctor visits and medical treatments.
Why It Matters
This study quantifies the hidden economic burden of ME/CFS beyond direct medical costs, showing that informal caregiving and employment loss represent the largest financial impact. Understanding these costs helps advocate for healthcare resources, workplace accommodations, and research funding for treatments that could reduce disability and improve productivity.
Observed Findings
- Mean total 3-month cost across all patients was £1,906, with formal healthcare services representing only 9.3% of total costs.
- Patients with CFS had higher unadjusted total costs (£3,515) compared to those with chronic fatigue alone (£1,176).
- Over 90% of costs were attributed to informal care from family and friends and lost employment.
- Patients with dependants incurred significantly higher costs than those without dependants.
- Greater functional impairment was associated with significantly higher costs.
Inferred Conclusions
- ME/CFS imposes substantial economic burden on society, primarily through informal care and lost employment rather than formal healthcare spending.
- The economic impact of CFS extends beyond direct medical costs, suggesting treatments targeting functional impairment could yield substantial economic benefits.
- Informal caregiving represents a critical but often unrecognized economic and social cost of ME/CFS.
Remaining Questions
- What is the long-term trajectory of costs in ME/CFS patients, and do they vary by disease duration or severity stage?
- Which specific treatments or interventions could reduce informal care burden or employment loss, and what would be their cost-effectiveness?
What This Study Does Not Prove
This study does not establish causation or prove that ME/CFS directly causes employment loss or specific care needs—only that these costs occur together. It cannot determine whether costs are stable long-term or how they might change with treatment. The cross-sectional design captures only a 3-month snapshot and cannot track individual patients over time.
Tags
Symptom:Fatigue
Method Flag:Weak Case DefinitionExploratory OnlyMixed CohortPEM Not Defined
Metadata
- DOI
- 10.1017/s0033291702006980
- PMID
- 12622304
- Review status
- Editor reviewed
- Evidence level
- Single-study or moderate support from human research
- Last updated
- 12 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.